BioLineRx
| Use attributes for filter ! | |
| Stock price | BLRX |
|---|---|
| Disclaimer | |
| Headquarters | Modi'in-Maccabim-Re'ut |
| Israel | |
| Ceo | Philip A. Serlin |
| Founded | 2003 |
| Subsidiaries | Agalimmune Limited |
| Bioline Innovations Jerusalem L. p | |
| Owners | Novartis |
| Senvest Management, LLC | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2619086 |
About BioLineRx
BioLineRx, or BioLine, is a publicly traded drug development company that seeks to discover compounds for disease treatment and develop them into commercializable drugs. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.
